Chapin Davis, Inc. Astrazeneca PLC Transaction History
Chapin Davis, Inc.
- $407 Billion
- Q3 2025
A detailed history of Chapin Davis, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Chapin Davis, Inc. holds 3,795 shares of AZN stock, worth $319,007. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,795
Previous 3,675
3.27%
Holding current value
$319,007
Previous $257 Million
13.37%
% of portfolio
0.07%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,444Shares Held
497MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.37 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.64 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.62 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $261B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...